AI is shaping buyer shortlists long before your pipeline records an opportunity. An AI visibility assessment doesn’t just measure whether you show up, it tests whether AI tells the right story and treats you as a credible choice. Here’s the diagnostic framework we’ve been testing to score visibility, accuracy, and credibility across platforms.
How to Know If AI Is Helping or Hurting Your Pipeline Read More »
Your pipeline isn’t showing you what you’re actually losing. There’s an entire discovery layer shaping buyer shortlists where most mid-market companies have zero visibility, zero measurement, and zero ability to detect missed opportunities. The risk isn’t what you can see. It’s what never shows up.
The Deals You’re Losing Before They Start Read More »
A speculative memo about AI’s economic impact is making the rounds. It imagines a world where machine intelligence reshapes entire industries by 2028. Whether the timeline is right or not, one thing is already happening: AI is deciding which companies your buyers see. And most B2B companies have no idea where they stand.
Your Next Buyer Won’t Google You. They’ll Ask AI. Read More »
Deals can look clean in diligence and still hide a fragile growth engine. Here are nine GTM diligence questions investors should ask pre-close to surface ICP drift, handoff breakdowns, funnel friction, and non-repeatable sales, before spend turns a fragile motion into an expensive problem.. And if you want the checklist in one place, there’s a downloadable GTM Question Guide.
The GTM Questions Smart Investors Ask Before They Close Read More »
The deal model looked solid. The pipeline was real. Capital was ready. But no one asked whether the conditions that produced those numbers were repeatable under new ownership and higher expectations. Twelve months later, the answer was obvious. The question is what you do before that point.
The Hidden Cost of “We’ll Fix GTM Later” Read More »
When competing priorities pile up, most teams don’t need motivation…they need a decision.
The hard question isn’t “How do we do both?” It’s “Which one matters more right now?” Answer that honestly, and the path forward won’t get easier. But it will get clear.
The Multiple Priorities Illusion Read More »
When growth slips, “do more” is seductive. It feels safe and it relieves the pressure for the moment. It’s also expensive.
New hires, new tools, and new campaigns can’t compensate for unclear positioning or a broken GTM motion.
When you’re standing on that cliff, there’s something critical you need to do first…
Read This Before You Spend Another Dollar on Growth Read More »
Most B2B teams don’t overspend on tactics, they overspend on guessing.
Like a physical for your go-to-market, a growth diagnostic pressure-tests the foundations (ICP, differentiation, handoffs, leadership assumptions) before you scale hires, agencies, or campaigns.
Here’s more detail on what it actually looks at, what it prevents, and why it’s usually a lot cheaper than your next mistake.
How Much Does a Growth Diagnostic Cost and Is It Worth It? Read More »
When B2B growth stalls, leaders are quick to act on symptoms to ease the pressure. But this doesn’t get to the root cause of the growth issue. The real constraint is often structural: ICP drift, muddled positioning, broken handoffs, and metrics no one trusts.
The smarter approach is to execute a B2B growth diagnostic to reveal the real constraints and blind spots in your growth engine.
Why B2B Companies Waste Time Fixing the Wrong Growth Problems Read More »
Every January, we reset the spreadsheet and call it a plan. But if the team, process, and constraints don’t change, the results won’t either.
False optimism is belief without change. Real optimism is earned by defining what needs to be true and tracking early markers that force action.
The Calendar Changed. Have we? Read More »
